Marketing - Press Releases

Date	Title	Company
15-Dec-2020	Primary care committed to Covid vaccine programme but needs support	NHS Confederation
15-Dec-2020	COVID-19 has made little positive impact on public perceptions of pharma, report suggests	Takeda UK
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization	Carterra, Inc
15-Dec-2020	True Medical Partners with Trulioo to Provide Real-Time Identity Verification During Digital Onboarding and Meet Regulatory Compliance	Trulioo
15-Dec-2020	MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials	MinervaX
15-Dec-2020	Imfinzi recommended for approval in the EU by CHMP for less-frequent, fixed-dose use in unresectable non-small cell lung cancer	AstraZeneca
15-Dec-2020	Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™	Acacia Pharma
15-Dec-2020	Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030	Sanofi
14-Dec-2020	CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes	Sanofi
14-Dec-2020	BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma	Merck and Pfizer
14-Dec-2020	TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy	SAREUM HOLDINGS PLC
14-Dec-2020	OncoZenge raises MSEK 10 ahead of spin-off and separate listing	Moberg Pharma
14-Dec-2020	HBC and Tenet Partners initiate a long-term collaboration to build a global brand and launch HBC’s own branded consumer health products	Hofseth BioCare ASA
14-Dec-2020	Emapalumab submission in China for primary HLH	Orphan Biovitrum AB
14-Dec-2020	Novo Holdings Creates New Rare Bleeding Disorder Company, Hemab	Novo Holdings
14-Dec-2020	Trixeo Aerosphere approved in the EU for maintenance treatment of COPD	AstraZeneca
14-Dec-2020	Celltrion Healthcare receives EU CHMP positive opinion for biosimilar adalimumab, CT-P17	Celltrion Healthcare
10-Dec-2020	Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates	Boehringer Ingelheim
10-Dec-2020	University spin-out fund makes half a million pound first investments	Northern Accelerator